Abstract
Slaughter et al. use proteomic and genomic approaches to quantitatively assess the impact of histone deacetylase inhibitor (HDACi) treatment on histone acetylation and BRD4 binding genome-wide. Their studies show that HDACi treatment causes histone polyacetylation and recruitment of BRD4, particularly in the gene bodies of actively transcribed genes.
Original language | English |
---|---|
Article number | 108638 |
Journal | Cell Reports |
Volume | 34 |
Issue number | 3 |
DOIs | |
State | Published - Jan 19 2021 |
Keywords
- BRD4
- HDAC
- bromodomain
- chromatin immunoprecipitation
- histone acetylation
- mass spectrometry
- peptide microarray
- superenhancer
- transcription